| Product NDC: | 33342-019 |
| Proprietary Name: | Pantoprazole sodium |
| Non Proprietary Name: | Pantoprazole sodium |
| Active Ingredient(s): | 20 mg/1 & nbsp; Pantoprazole sodium |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, DELAYED RELEASE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 33342-019 |
| Labeler Name: | Macleods Pharmaceuticals Limited |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA200821 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20111203 |
| Package NDC: | 33342-019-10 |
| Package Description: | 90 TABLET, DELAYED RELEASE in 1 BOTTLE (33342-019-10) |
| NDC Code | 33342-019-10 |
| Proprietary Name | Pantoprazole sodium |
| Package Description | 90 TABLET, DELAYED RELEASE in 1 BOTTLE (33342-019-10) |
| Product NDC | 33342-019 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Pantoprazole sodium |
| Dosage Form Name | TABLET, DELAYED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20111203 |
| Marketing Category Name | ANDA |
| Labeler Name | Macleods Pharmaceuticals Limited |
| Substance Name | PANTOPRAZOLE SODIUM |
| Strength Number | 20 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA] |